ReviewWiley interdisciplinary reviews. RNA
Machine Learning to Enhance Biophysical Models for Riboswitch Discovery.
Review in Wiley interdisciplinary reviews. RNA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning to Enhance Biophysical Models for Riboswitch Discovery.Wiley interdisciplinary reviews. RNAReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Riboswitches are RNA-based genetic control elements that provide a unique mechanism of gene regulation. They function without the participation of proteins and are believed to represent ancient regulatory systems on the evolutionary timescale. To expand the search for novel riboswitches of significant interest, such as eukaryotic riboswitches beyond the purine riboswitch class, the integration of machine learning into RNA design offers considerable potential to improve the effectiveness of traditional search methods. Many riboswitch aptamers that could be targeted in such searches are larger than purine riboswitch aptamers, making their design time-consuming (e.g., SAM, lysine, FMN, glycine, and cobalamin riboswitches). In an example problem unrelated to the discovery of novel riboswitches, namely challenges in the eteRNA game, it has been shown that a transformer encoder-decoder model is effective in solving difficult inverse RNA folding challenges. In the outlined approach, machine learning is used as a preprocessing step before RNA design, rather than relying on random inputs to the Monte Carlo method, and the RNA design step crucially depends on a biophysical model for the forward problem of RNA folding prediction. It is therefore suggested to optimize the training of the machine learning model and then utilize this approach for riboswitch discovery to make searches for riboswitches larger than purine aptamers more efficient and robust.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.